English

IMPAX LABORATORIES INC

EDGAR

IPXL Quarterly report (10-Q) · filed 2018-05-10

89 filing records in this dataset, filed from 1996-05-09 to 2018-05-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

142 million USD

2018 Q1 · USD

Exact inputs and evidence

Revenue: 142355000 USD Source

Operating margin

-87.72%

2018 Q1 · %

Exact inputs and evidence

Operating Income: -124876000 USD Source
Revenue: 142355000 USD Source

Operating cash flow

-85.5 million USD

2018 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -85480000 USD Source

Free cash flow

-89.4 million USD

2018 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -85480000 USD Source
Capital Expenditure: 3958000 USD Source

Cash and cash equivalents: 104 million USD 2018-03-31 Source
Exact value

104192000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 73.8 million shares 2018-03-31 Source
Exact value

73836907 shares

Reported share-count change

0.04% · 32.4 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

73804474 shares · 2017-03-31· Source
73836907 shares · 2018-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

734 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Revenue: 202082000 USD · 2017-04-01 – 2017-06-30 Source
Revenue: 206392000 USD · 2017-07-01 – 2017-09-30 Source
Revenue: 182910000 USD · 2017-10-01 – 2017-12-31 Source
Revenue: 142355000 USD · 2018-01-01 – 2018-03-31 Source

Net income

-502 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Net income: -20417000 USD · 2017-04-01 – 2017-06-30 Source
Net income: -49369000 USD · 2017-07-01 – 2017-09-30 Source
Net income: -301070000 USD · 2017-10-01 – 2017-12-31 Source
Net income: -130932000 USD · 2018-01-01 – 2018-03-31 Source

Operating cash flow

-41.1 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Operating cash flow: 58191000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 39805000 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 46809000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 58191000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 84222000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 46809000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -85480000 USD · 2018-01-01 – 2018-03-31 Source

Capital expenditure

22 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Capital expenditure: 18993000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 8679000 USD · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 24177000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 18993000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 26749000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 24177000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 3958000 USD · 2018-01-01 – 2018-03-31 Source

Free cash flow

-63.1 million USD

2017-04-01 – 2018-03-31

Exact inputs and evidence

Operating cash flow: 58191000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 39805000 USD · 2017-01-01 – 2017-03-31 Source
Operating cash flow: 46809000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: 58191000 USD · 2017-01-01 – 2017-06-30 Source
Operating cash flow: 84222000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 46809000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -85480000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 18993000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 8679000 USD · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 24177000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 18993000 USD · 2017-01-01 – 2017-06-30 Source
Capital expenditure: 26749000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 24177000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 3958000 USD · 2018-01-01 – 2018-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-05-10.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2017-12-31
Operating income: 11 of 11 periods available· newest 2017-12-31
Net income: 11 of 11 periods available· newest 2017-12-31
Operating cash flow: 11 of 11 periods available· newest 2017-12-31
Capital expenditure: 11 of 11 periods available· newest 2017-12-31
Total assets: 11 of 11 periods available· newest 2017-12-31
Total liabilities: 11 of 11 periods available· newest 2017-12-31
Current assets: 11 of 11 periods available· newest 2017-12-31
Current liabilities: 11 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2017-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2017-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-5.9%

Prior period

USD 824.43 million

2016-01-01 – 2016-12-31
Current period

USD 775.79 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

775787000 − 824429000 = -48642000 USD

824429000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
775787000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Year-over-year change in Revenue: -48642000 USD Concept: fundies:Revenue Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 775787000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#707895 Filing: 000100364218000038 Input fundies:Revenue: 824429000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#702814 Filing: 000100364218000038
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.74 million

Prior period

−USD 472.03 million

2016-01-01 – 2016-12-31
Current period

−USD 469.29 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-469287000 − -472031000 = 2744000 USD

-472031000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-469287000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Year-over-year change in Net income: 2744000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -469287000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#636843 Filing: 000100364218000038 Input fundies:NetIncome: -472031000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#635563 Filing: 000100364218000038
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+0.4%

Prior period

USD 83.85 million

2016-01-01 – 2016-12-31
Current period

USD 84.22 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

84222000 − 83850000 = 372000 USD

83850000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
84222000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Year-over-year change in Operating cash flow: 372000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 84222000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632833 Filing: 000100364218000038 Input fundies:OperatingCashFlow: 83850000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632312 Filing: 000100364218000038
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-45.9%

Prior period

USD 49.4 million

2016-01-01 – 2016-12-31
Current period

USD 26.75 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

26749000 − 49402000 = -22653000 USD

49402000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
26749000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Year-over-year change in Capital expenditure: -22653000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 26749000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655951 Filing: 000100364218000038 Input fundies:CapitalExpenditure: 49402000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655740 Filing: 000100364218000038
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2017 2017-01-01 – 2017-12-31

Revenue USD 775.79 million 100% of revenue
Cost of revenue USD 535.12 million 69% of revenue
Operating expenses USD 546.49 million 70% of revenue
Other operating costs Derived USD 96.87 million 12% of revenue
Operating income −USD 402.69 million −52% of revenue
Tax, interest and other Derived USD 66.6 million 8.6% of revenue
Net income −USD 469.29 million −60% of revenue

Cash

Operating cash flow USD 84.22 million 11% of revenue
Capital expenditure USD 26.75 million 3.4% of revenue
Free cash flow Derived USD 57.47 million 7.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Net income was higher than operating income, so the split is not drawn.
2009 14%80%
2010 28%16%55%
2011 13%81%
2012 9.6%86%
2013 Operating loss: operating costs were 101% of revenue.
2014 9.6%85%
2015 92%
2016 Operating loss: operating costs were 160% of revenue.
2017 Operating loss: operating costs were 152% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	210071000	206148000 Derived	3923000	-14777000 Derived	18700000	38701000 Derived	Source 2008-01-01 – 2008-12-31: 210071000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 3923000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 18700000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 64564000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 25863000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	358409000	287996000 Derived	70413000	20352000 Derived	50061000	-21824000 Derived	Source 2009-01-01 – 2009-12-31: 358409000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 70413000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 50061000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -8157000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 13667000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	879509000	486185000 Derived	393324000	142906000 Derived	250418000	233494000 Derived	Source 2010-01-01 – 2010-12-31: 879509000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 393324000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 250418000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 249761000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 16267000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	512919000	413308000 Derived	99611000	34116000 Derived	65495000	-24397000 Derived	Source 2011-01-01 – 2011-12-31: 512919000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 99611000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 65495000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 6127000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 30524000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	581692000	498700000 Derived	82992000	27119000 Derived	55873000	38929000 Derived	Source 2012-01-01 – 2012-12-31: 581692000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 82992000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 55873000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 105829000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 66900000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	511502000	517889000 Derived	-6387000	-107646000 Derived	101259000	117155000 Derived	Source 2013-01-01 – 2013-12-31: 511502000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -6387000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 101259000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 149940000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 32785000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	596049000	507233000 Derived	88816000	31463000 Derived	57353000	2904000 Derived	Source 2014-01-01 – 2014-12-31: 596049000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 88816000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 57353000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 32817000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 29913000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	860469000	790901000 Derived	69568000	30571000 Derived	38997000	67253000 Derived	Source 2015-01-01 – 2015-12-31: 860469000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 69568000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 38997000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 92452000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 25199000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	824429000	1318611000 Derived	-494182000	-22151000 Derived	-472031000	34448000 Derived	Source 2016-01-01 – 2016-12-31: 824429000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -494182000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -472031000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 83850000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 49402000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	775787000	1178479000 Derived	-402692000	66595000 Derived	-469287000	57473000 Derived	Source 2017-01-01 – 2017-12-31: 775787000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -402692000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -469287000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 84222000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 26749000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 775.8M 2017

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	210071000	Revenue: 210071000 Open source
20092009-12-31	Revenue	358409000	Revenue: 358409000 Open source
20102010-12-31	Revenue	879509000	Revenue: 879509000 Open source
20112011-12-31	Revenue	512919000	Revenue: 512919000 Open source
20122012-12-31	Revenue	581692000	Revenue: 581692000 Open source
20132013-12-31	Revenue	511502000	Revenue: 511502000 Open source
20142014-12-31	Revenue	596049000	Revenue: 596049000 Open source
20152015-12-31	Revenue	860469000	Revenue: 860469000 Open source
20162016-12-31	Revenue	824429000	Revenue: 824429000 Open source
20172017-12-31	Revenue	775787000	Revenue: 775787000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-5.9% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	-23.3%	Revenue: 210071000 Open source Revenue: 273753000 Open source
20092009-12-31	Year over year	70.6%	Revenue: 358409000 Open source Revenue: 210071000 Open source
20102010-12-31	Year over year	145.4%	Revenue: 879509000 Open source Revenue: 358409000 Open source
20112011-12-31	Year over year	-41.7%	Revenue: 512919000 Open source Revenue: 879509000 Open source
20122012-12-31	Year over year	13.4%	Revenue: 581692000 Open source Revenue: 512919000 Open source
20132013-12-31	Year over year	-12.1%	Revenue: 511502000 Open source Revenue: 581692000 Open source
20142014-12-31	Year over year	16.5%	Revenue: 596049000 Open source Revenue: 511502000 Open source
20152015-12-31	Year over year	44.4%	Revenue: 860469000 Open source Revenue: 596049000 Open source
20162016-12-31	Year over year	-4.2%	Revenue: 824429000 Open source Revenue: 860469000 Open source
20172017-12-31	Year over year	-5.9%	Revenue: 775787000 Open source Revenue: 824429000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -51.9% 2017

Net margin -60.5% 2017

Free cash flow margin 7.4% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	1.9%	Operating Income: 3923000 Open source Revenue: 210071000 Open source
20092009-12-31	Operating margin	19.6%	Operating Income: 70413000 Open source Revenue: 358409000 Open source
20102010-12-31	Operating margin	44.7%	Operating Income: 393324000 Open source Revenue: 879509000 Open source
20112011-12-31	Operating margin	19.4%	Operating Income: 99611000 Open source Revenue: 512919000 Open source
20122012-12-31	Operating margin	14.3%	Operating Income: 82992000 Open source Revenue: 581692000 Open source
20132013-12-31	Operating margin	-1.2%	Operating Income: -6387000 Open source Revenue: 511502000 Open source
20142014-12-31	Operating margin	14.9%	Operating Income: 88816000 Open source Revenue: 596049000 Open source
20152015-12-31	Operating margin	8.1%	Operating Income: 69568000 Open source Revenue: 860469000 Open source
20162016-12-31	Operating margin	-59.9%	Operating Income: -494182000 Open source Revenue: 824429000 Open source
20172017-12-31	Operating margin	-51.9%	Operating Income: -402692000 Open source Revenue: 775787000 Open source
20082008-12-31	Net margin	8.9%	Net Income: 18700000 Open source Revenue: 210071000 Open source
20092009-12-31	Net margin	14%	Net Income: 50061000 Open source Revenue: 358409000 Open source
20102010-12-31	Net margin	28.5%	Net Income: 250418000 Open source Revenue: 879509000 Open source
20112011-12-31	Net margin	12.8%	Net Income: 65495000 Open source Revenue: 512919000 Open source
20122012-12-31	Net margin	9.6%	Net Income: 55873000 Open source Revenue: 581692000 Open source
20132013-12-31	Net margin	19.8%	Net Income: 101259000 Open source Revenue: 511502000 Open source
20142014-12-31	Net margin	9.6%	Net Income: 57353000 Open source Revenue: 596049000 Open source
20152015-12-31	Net margin	4.5%	Net Income: 38997000 Open source Revenue: 860469000 Open source
20162016-12-31	Net margin	-57.3%	Net Income: -472031000 Open source Revenue: 824429000 Open source
20172017-12-31	Net margin	-60.5%	Net Income: -469287000 Open source Revenue: 775787000 Open source
20082008-12-31	Free cash flow margin	18.4%	Revenue: 210071000 Open source Operating Cash Flow: 64564000 Open source Capital Expenditure: 25863000 Open source
20092009-12-31	Free cash flow margin	-6.1%	Revenue: 358409000 Open source Operating Cash Flow: -8157000 Open source Capital Expenditure: 13667000 Open source
20102010-12-31	Free cash flow margin	26.5%	Revenue: 879509000 Open source Operating Cash Flow: 249761000 Open source Capital Expenditure: 16267000 Open source
20112011-12-31	Free cash flow margin	-4.8%	Revenue: 512919000 Open source Operating Cash Flow: 6127000 Open source Capital Expenditure: 30524000 Open source
20122012-12-31	Free cash flow margin	6.7%	Revenue: 581692000 Open source Operating Cash Flow: 105829000 Open source Capital Expenditure: 66900000 Open source
20132013-12-31	Free cash flow margin	22.9%	Revenue: 511502000 Open source Operating Cash Flow: 149940000 Open source Capital Expenditure: 32785000 Open source
20142014-12-31	Free cash flow margin	0.5%	Revenue: 596049000 Open source Operating Cash Flow: 32817000 Open source Capital Expenditure: 29913000 Open source
20152015-12-31	Free cash flow margin	7.8%	Revenue: 860469000 Open source Operating Cash Flow: 92452000 Open source Capital Expenditure: 25199000 Open source
20162016-12-31	Free cash flow margin	4.2%	Revenue: 824429000 Open source Operating Cash Flow: 83850000 Open source Capital Expenditure: 49402000 Open source
20172017-12-31	Free cash flow margin	7.4%	Revenue: 775787000 Open source Operating Cash Flow: 84222000 Open source Capital Expenditure: 26749000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 84.2M 2017

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	64564000	Operating Cash Flow: 64564000 Open source
20092009-12-31	Operating cash flow	-8157000	Operating Cash Flow: -8157000 Open source
20102010-12-31	Operating cash flow	249761000	Operating Cash Flow: 249761000 Open source
20112011-12-31	Operating cash flow	6127000	Operating Cash Flow: 6127000 Open source
20122012-12-31	Operating cash flow	105829000	Operating Cash Flow: 105829000 Open source
20132013-12-31	Operating cash flow	149940000	Operating Cash Flow: 149940000 Open source
20142014-12-31	Operating cash flow	32817000	Operating Cash Flow: 32817000 Open source
20152015-12-31	Operating cash flow	92452000	Operating Cash Flow: 92452000 Open source
20162016-12-31	Operating cash flow	83850000	Operating Cash Flow: 83850000 Open source
20172017-12-31	Operating cash flow	84222000	Operating Cash Flow: 84222000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 57.5M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	38701000	Operating Cash Flow: 64564000 Open source Capital Expenditure: 25863000 Open source
20092009-12-31	Free cash flow	-21824000	Operating Cash Flow: -8157000 Open source Capital Expenditure: 13667000 Open source
20102010-12-31	Free cash flow	233494000	Operating Cash Flow: 249761000 Open source Capital Expenditure: 16267000 Open source
20112011-12-31	Free cash flow	-24397000	Operating Cash Flow: 6127000 Open source Capital Expenditure: 30524000 Open source
20122012-12-31	Free cash flow	38929000	Operating Cash Flow: 105829000 Open source Capital Expenditure: 66900000 Open source
20132013-12-31	Free cash flow	117155000	Operating Cash Flow: 149940000 Open source Capital Expenditure: 32785000 Open source
20142014-12-31	Free cash flow	2904000	Operating Cash Flow: 32817000 Open source Capital Expenditure: 29913000 Open source
20152015-12-31	Free cash flow	67253000	Operating Cash Flow: 92452000 Open source Capital Expenditure: 25199000 Open source
20162016-12-31	Free cash flow	34448000	Operating Cash Flow: 83850000 Open source Capital Expenditure: 49402000 Open source
20172017-12-31	Free cash flow	57473000	Operating Cash Flow: 84222000 Open source Capital Expenditure: 26749000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

86.1% 2017

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	69%	Total Liabilities: 354637000 Open source Total Assets: 514287000 Open source
20092009-12-31	Liabilities / assets	66.4%	Total Liabilities: 438529000 Open source Total Assets: 660756000 Open source
20102010-12-31	Liabilities / assets	26.7%	Total Liabilities: 185169000 Open source Total Assets: 693318000 Open source
20112011-12-31	Liabilities / assets	24%	Total Liabilities: 190918000 Open source Total Assets: 793859000 Open source
20122012-12-31	Liabilities / assets	20%	Total Liabilities: 172867000 Open source Total Assets: 863970000 Open source
20132013-12-31	Liabilities / assets	18.7%	Total Liabilities: 186720000 Open source Total Assets: 996923000 Open source
20142014-12-31	Liabilities / assets	17.7%	Total Liabilities: 191320000 Open source Total Assets: 1079197000 Open source
20152015-12-31	Liabilities / assets	44.7%	Total Liabilities: 860078000 Open source Total Assets: 1922487000 Open source
20162016-12-31	Liabilities / assets	65.8%	Total Liabilities: 1199044000 Open source Total Assets: 1823018000 Open source
20172017-12-31	Liabilities / assets	86.1%	Total Liabilities: 1164099000 Open source Total Assets: 1351300000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.96× 2017

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	2.16×	Current Assets: 236372000 Open source Current Liabilities: 109588000 Open source
20092009-12-31	Current assets / current liabilities	1.83×	Current Assets: 374011000 Open source Current Liabilities: 203868000 Open source
20102010-12-31	Current assets / current liabilities	4.12×	Current Assets: 520694000 Open source Current Liabilities: 126416000 Open source
20112011-12-31	Current assets / current liabilities	3.82×	Current Assets: 599935000 Open source Current Liabilities: 156861000 Open source
20122012-12-31	Current assets / current liabilities	3.75×	Current Assets: 545543000 Open source Current Liabilities: 145295000 Open source
20132013-12-31	Current assets / current liabilities	4.29×	Current Assets: 659742000 Open source Current Liabilities: 153890000 Open source
20142014-12-31	Current assets / current liabilities	4.26×	Current Assets: 675626000 Open source Current Liabilities: 158699000 Open source
20152015-12-31	Current assets / current liabilities	2.52×	Current Assets: 822073000 Open source Current Liabilities: 326761000 Open source
20162016-12-31	Current assets / current liabilities	1.96×	Current Assets: 631141000 Open source Current Liabilities: 321324000 Open source
20172017-12-31	Current assets / current liabilities	1.96×	Current Assets: 695555000 Open source Current Liabilities: 354238000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	USD 18.7 million Exact value Exact value: 18700000 USD 2008-01-01 – 2008-12-31: 18700000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2008-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 18700000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18700000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/0000893220-09-000533.txt#24165 The citation records this snapshot. The page link may show a newer release later.	USD 64.56 million Exact value Exact value: 64564000 USD 2008-01-01 – 2008-12-31: 64564000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2008-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 64564000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 64564000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/0000950123-11-018461.txt#17619 The citation records this snapshot. The page link may show a newer release later.	USD 25.86 million Exact value Exact value: 25863000 USD 2008-01-01 – 2008-12-31: 25863000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2008-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 25863000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25863000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/0000950123-11-018461.txt#17721 The citation records this snapshot. The page link may show a newer release later.	USD 38.7 million Calculation and evidence 64564000 − 25863000 USD Exact free cash flow: 38701000 USD 2008-01-01 – 2008-12-31: 64564000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 25863000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2008-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 38701000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 64564000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/0000950123-11-018461.txt#17619 Input fundies:CapitalExpenditure: 25863000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/0000950123-11-018461.txt#17721 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 50.06 million Exact value Exact value: 50061000 USD 2009-01-01 – 2009-12-31: 50061000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2009-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 50061000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 50061000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000119312512085404/ipxl-20111231.xml#112550 Filing: 000119312512085404 The citation records this snapshot. The page link may show a newer release later.	−USD 8.16 million Exact value Exact value: -8157000 USD 2009-01-01 – 2009-12-31: -8157000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2009-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: -8157000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8157000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000119312512085404/ipxl-20111231.xml#106543 Filing: 000119312512085404 The citation records this snapshot. The page link may show a newer release later.	USD 13.67 million Exact value Exact value: 13667000 USD 2009-01-01 – 2009-12-31: 13667000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2009-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 13667000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13667000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000119312512085404/ipxl-20111231.xml#114929 Filing: 000119312512085404 The citation records this snapshot. The page link may show a newer release later.	−USD 21.82 million Calculation and evidence -8157000 − 13667000 USD Exact free cash flow: -21824000 USD 2009-01-01 – 2009-12-31: -8157000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 13667000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2009-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: -21824000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8157000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000119312512085404/ipxl-20111231.xml#106543 Filing: 000119312512085404 Input fundies:CapitalExpenditure: 13667000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000119312512085404/ipxl-20111231.xml#114929 Filing: 000119312512085404 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 250.42 million Exact value Exact value: 250418000 USD 2010-01-01 – 2010-12-31: 250418000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2010-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 250418000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 250418000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774913001948/ipxl-20121231.xml#208556 Filing: 000143774913001948 The citation records this snapshot. The page link may show a newer release later.	USD 249.76 million Exact value Exact value: 249761000 USD 2010-01-01 – 2010-12-31: 249761000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2010-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 249761000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 249761000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774913001948/ipxl-20121231.xml#235578 Filing: 000143774913001948 The citation records this snapshot. The page link may show a newer release later.	USD 16.27 million Exact value Exact value: 16267000 USD 2010-01-01 – 2010-12-31: 16267000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2010-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 16267000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16267000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774913001948/ipxl-20121231.xml#237388 Filing: 000143774913001948 The citation records this snapshot. The page link may show a newer release later.	USD 233.49 million Calculation and evidence 249761000 − 16267000 USD Exact free cash flow: 233494000 USD 2010-01-01 – 2010-12-31: 249761000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 16267000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2010-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 233494000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 249761000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774913001948/ipxl-20121231.xml#235578 Filing: 000143774913001948 Input fundies:CapitalExpenditure: 16267000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774913001948/ipxl-20121231.xml#237388 Filing: 000143774913001948 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 65.5 million Exact value Exact value: 65495000 USD 2011-01-01 – 2011-12-31: 65495000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2011-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 65495000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 65495000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774914002682/ipxl-20131231.xml#226970 Filing: 000143774914002682 The citation records this snapshot. The page link may show a newer release later.	USD 6.13 million Exact value Exact value: 6127000 USD 2011-01-01 – 2011-12-31: 6127000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2011-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 6127000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6127000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774914002682/ipxl-20131231.xml#253127 Filing: 000143774914002682 The citation records this snapshot. The page link may show a newer release later.	USD 30.52 million Exact value Exact value: 30524000 USD 2011-01-01 – 2011-12-31: 30524000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2011-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 30524000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 30524000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774914002682/ipxl-20131231.xml#254935 Filing: 000143774914002682 The citation records this snapshot. The page link may show a newer release later.	−USD 24.4 million Calculation and evidence 6127000 − 30524000 USD Exact free cash flow: -24397000 USD 2011-01-01 – 2011-12-31: 6127000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 30524000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2011-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: -24397000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6127000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774914002682/ipxl-20131231.xml#253127 Filing: 000143774914002682 Input fundies:CapitalExpenditure: 30524000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774914002682/ipxl-20131231.xml#254935 Filing: 000143774914002682 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 55.87 million Exact value Exact value: 55873000 USD 2012-01-01 – 2012-12-31: 55873000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2012-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 55873000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 55873000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774915003537/ipxl-20141231.xml#236578 Filing: 000143774915003537 The citation records this snapshot. The page link may show a newer release later.	USD 105.83 million Exact value Exact value: 105829000 USD 2012-01-01 – 2012-12-31: 105829000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2012-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 105829000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 105829000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774915003537/ipxl-20141231.xml#262351 Filing: 000143774915003537 The citation records this snapshot. The page link may show a newer release later.	USD 66.9 million Exact value Exact value: 66900000 USD 2012-01-01 – 2012-12-31: 66900000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2012-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 66900000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 66900000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774915003537/ipxl-20141231.xml#264161 Filing: 000143774915003537 The citation records this snapshot. The page link may show a newer release later.	USD 38.93 million Calculation and evidence 105829000 − 66900000 USD Exact free cash flow: 38929000 USD 2012-01-01 – 2012-12-31: 105829000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 66900000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2012-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 38929000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 105829000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774915003537/ipxl-20141231.xml#262351 Filing: 000143774915003537 Input fundies:CapitalExpenditure: 66900000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774915003537/ipxl-20141231.xml#264161 Filing: 000143774915003537 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 101.26 million Exact value Exact value: 101259000 USD 2013-01-01 – 2013-12-31: 101259000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2013-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 101259000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 101259000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#293858 Filing: 000143774916025780 The citation records this snapshot. The page link may show a newer release later.	USD 149.94 million Exact value Exact value: 149940000 USD 2013-01-01 – 2013-12-31: 149940000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2013-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 149940000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 149940000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#320723 Filing: 000143774916025780 The citation records this snapshot. The page link may show a newer release later.	USD 32.79 million Exact value Exact value: 32785000 USD 2013-01-01 – 2013-12-31: 32785000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2013-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 32785000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 32785000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#321694 Filing: 000143774916025780 The citation records this snapshot. The page link may show a newer release later.	USD 117.16 million Calculation and evidence 149940000 − 32785000 USD Exact free cash flow: 117155000 USD 2013-01-01 – 2013-12-31: 149940000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 32785000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2013-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 117155000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 149940000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#320723 Filing: 000143774916025780 Input fundies:CapitalExpenditure: 32785000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#321694 Filing: 000143774916025780 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 57.35 million Exact value Exact value: 57353000 USD 2014-01-01 – 2014-12-31: 57353000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2014-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 57353000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 57353000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000143774916025780/ipxl-20151231.xml#293732 Filing: 000143774916025780 The citation records this snapshot. The page link may show a newer release later.	USD 32.82 million Exact value Exact value: 32817000 USD 2014-01-01 – 2014-12-31: 32817000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2014-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 32817000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 32817000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364217000017/ipxl-20161231.xml#641957 Filing: 000100364217000017 The citation records this snapshot. The page link may show a newer release later.	USD 29.91 million Exact value Exact value: 29913000 USD 2014-01-01 – 2014-12-31: 29913000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2014-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 29913000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29913000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364217000017/ipxl-20161231.xml#659099 Filing: 000100364217000017 The citation records this snapshot. The page link may show a newer release later.	USD 2.9 million Calculation and evidence 32817000 − 29913000 USD Exact free cash flow: 2904000 USD 2014-01-01 – 2014-12-31: 32817000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 29913000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2014-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 2904000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 32817000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364217000017/ipxl-20161231.xml#641957 Filing: 000100364217000017 Input fundies:CapitalExpenditure: 29913000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364217000017/ipxl-20161231.xml#659099 Filing: 000100364217000017 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 39 million Exact value Exact value: 38997000 USD 2015-01-01 – 2015-12-31: 38997000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2015-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: 38997000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 38997000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#633044 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 92.45 million Exact value Exact value: 92452000 USD 2015-01-01 – 2015-12-31: 92452000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2015-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 92452000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 92452000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#631790 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 25.2 million Exact value Exact value: 25199000 USD 2015-01-01 – 2015-12-31: 25199000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2015-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 25199000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25199000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655529 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 67.25 million Calculation and evidence 92452000 − 25199000 USD Exact free cash flow: 67253000 USD 2015-01-01 – 2015-12-31: 92452000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 25199000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2015-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 67253000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 92452000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#631790 Filing: 000100364218000038 Input fundies:CapitalExpenditure: 25199000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655529 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 472.03 million Exact value Exact value: -472031000 USD 2016-01-01 – 2016-12-31: -472031000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2016-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: -472031000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -472031000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#635563 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 83.85 million Exact value Exact value: 83850000 USD 2016-01-01 – 2016-12-31: 83850000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2016-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 83850000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 83850000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632312 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 49.4 million Exact value Exact value: 49402000 USD 2016-01-01 – 2016-12-31: 49402000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2016-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 49402000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49402000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655740 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 34.45 million Calculation and evidence 83850000 − 49402000 USD Exact free cash flow: 34448000 USD 2016-01-01 – 2016-12-31: 83850000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 49402000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2016-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 34448000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 83850000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632312 Filing: 000100364218000038 Input fundies:CapitalExpenditure: 49402000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655740 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 469.29 million Exact value Exact value: -469287000 USD 2017-01-01 – 2017-12-31: -469287000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Net Income: -469287000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -469287000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#636843 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 84.22 million Exact value Exact value: 84222000 USD 2017-01-01 – 2017-12-31: 84222000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Operating Cash Flow: 84222000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 84222000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632833 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 26.75 million Exact value Exact value: 26749000 USD 2017-01-01 – 2017-12-31: 26749000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Capital Expenditure: 26749000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26749000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655951 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.	USD 57.47 million Calculation and evidence 84222000 − 26749000 USD Exact free cash flow: 57473000 USD 2017-01-01 – 2017-12-31: 84222000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 26749000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMPAX LABORATORIES INC · 2017-12-31 IMPAX LABORATORIES INC (edgar:1003642) Free cash flow: 57473000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1003642?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 84222000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#632833 Filing: 000100364218000038 Input fundies:CapitalExpenditure: 26749000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1003642/000100364218000038/ipxl-20171231.xml#655951 Filing: 000100364218000038 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

89 filings · 4,499 latest values · 4,499 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001003642, 1003642, IPXL, edgar:1003642, ipxl

Also known as GLOBAL PHARMACEUTICAL CORP \DE\, IMPAX LABORATORIES INC, Impax Laboratories Inc., Impax Laboratories, LLC

IMPAX LABORATORIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2017 2017-01-01 – 2017-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation